| 16.04.2024 07:00 | FAB | Change of auditor | RNS |
| 15.04.2024 13:29 | FAB | Fusion Antibodies inks commercial contract for OptiPhage library | Alliance |
| 15.04.2024 07:00 | FAB | Contract to develop a bespoke OptiPhage library | RNS |
| 02.04.2024 14:34 | FAB | Block admission six monthly return | RNS |
| 28.03.2024 17:00 | FAB | Total Voting Rights | RNS |
| 11.03.2024 15:04 | FAB | Holding(s) in Company | RNS |
| 11.03.2024 09:10 | FAB | Holding(s) in Company | RNS |
| 08.03.2024 15:09 | FAB | Holding(s) in Company | RNS |
| 05.03.2024 10:40 | FAB | Result of General Meeting and Total Voting Rights | RNS |
| 29.02.2024 17:00 | FAB | Total Voting Rights | RNS |
| 27.02.2024 14:18 | CDL, DXRX, UOG | TRADING UPDATES: Sondrel wins USD23 million contract | Alliance |
| 27.02.2024 07:00 | FAB | First purchase order under MSA | RNS |
| 14.02.2024 11:27 | FAB | IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing | Alliance |
| 14.02.2024 07:15 | FAB | Grant of options and issue of shares to directors | RNS |
| 14.02.2024 07:00 | FAB | Placing to raise £1,375,000 | RNS |
| 06.02.2024 11:48 | FAB | Fusion Antibodies strikes follow-on research and development project | Alliance |
| 06.02.2024 10:05 | PCIP, FAB, BKS | AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations | Alliance |
| 01.02.2024 12:00 | FAB | Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform | Alliance |
| 04.12.2023 12:26 | FAB | Director/PDMR Shareholding | RNS |
| 04.12.2023 10:23 | FAB, DEMG, CSFS | AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations | Alliance |
| 04.12.2023 10:22 | FAB | Fusion Antibodies shares fall with revenue despite "positive" outlook | Alliance |
| 04.12.2023 07:00 | FAB | Half-year Report | RNS |
| 28.11.2023 12:09 | FAB | Fusion Antibodies shares up on deal with US National Cancer Institute | Alliance |
| 28.11.2023 10:33 | SUP, TLY, FAB | AIM WINNERS & LOSERS: Totally swings to half-year loss on NHS blow | Alliance |
| 28.11.2023 07:00 | FAB | OptiMAL collaboration agreement | RNS |
| 09.11.2023 12:54 | GENL, KDNC, EMH | EARNINGS AND TRADING: Wincanton profit down; James Cropper ups payout | Alliance |
| 09.11.2023 07:00 | FAB | Half year trading update | RNS |
| 27.10.2023 11:57 | FAB | Result of AGM | RNS |
| 04.10.2023 14:45 | FAB | Block admission six monthly return | RNS |
| 29.09.2023 21:19 | KEN, FAB, CPX | EARNINGS: Tan Delta revenue jumps; Kendrick Resources loss widens | Alliance |
| 29.09.2023 07:00 | FAB | Final Results | RNS |
| 29.08.2023 07:00 | FAB | Update on AI/ML-Ab service offering | RNS |
| 24.08.2023 12:10 | FAB | IN BRIEF: Fusion Antibodies appoints part-time CFO on cash struggles | Alliance |
| 24.08.2023 07:00 | FAB | Appointment of interim CFO | RNS |
| 21.08.2023 10:29 | REDX, FAB | AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens | Alliance |
| 21.08.2023 09:35 | FAB | Fusion Antibodies inks deal with AI learning firm, hails lower costs | Alliance |
| 21.08.2023 07:00 | FAB | Update on AI/ML-Ab™ antibody discovery service | RNS |
| 14.08.2023 08:41 | FAB | Fusion Antibodies completes "difficult" restructuring | Alliance |
| 14.08.2023 07:00 | FAB | Update on restructure and cost savings | RNS |
| 30.06.2023 17:00 | FAB | Total Voting Rights | RNS |
| 16.06.2023 10:09 | FAB | Holding(s) in Company | RNS |
| 15.06.2023 09:45 | FAB | Holding(s) in Company | RNS |
| 13.06.2023 14:44 | FAB | Holding(s) in Company | RNS |
| 12.06.2023 15:34 | FAB | Holding(s) in Company | RNS |
| 12.06.2023 11:02 | FAB | Director/PDMR Shareholding | RNS |
| 08.06.2023 10:39 | FAB | Result of GM and total voting rights | RNS |
| 01.06.2023 15:52 | EGY, RENX, PALM | UK shareholder meetings calendar - next 7 days | Alliance |
| 31.05.2023 17:00 | FAB | Total Voting Rights | RNS |
| 26.05.2023 16:57 | FAB | Holding(s) in Company | RNS |
| 26.05.2023 13:33 | FAB | Holding(s) in Company | RNS |
| 23.05.2023 07:00 | FAB | Result of Retail Offer and Notice of GM | RNS |
| 19.05.2023 11:43 | FAB | IN BRIEF: Fusion Antibodies shares drop after placing at 84% discount | Alliance |
| 19.05.2023 10:01 | FAB | REX Retail Offer | RNS |
| 19.05.2023 10:00 | FAB | Placing, Subscription and Retail Offer | RNS |
| 03.04.2023 07:00 | FAB | Block listing Interim Review | RNS |
| 31.03.2023 07:00 | FAB | Change of Registered Office | RNS |
| 21.03.2023 10:58 | FAB | Fusion Antibodies files patent application for cancer treatment | Alliance |
| 21.03.2023 07:00 | FAB | Patent application | Reach |
| 06.03.2023 11:05 | FAB | Second Price Monitoring Extn | RNS |
| 06.03.2023 11:00 | FAB | Price Monitoring Extension | RNS |
| 06.03.2023 10:52 | FAB | Fusion Antibodies drops as annual revenue seen significantly lower | Alliance |
| 06.03.2023 10:48 | FAB, POS, AMC | AIM WINNERS & LOSERS: Amur to pay dividends after disposal completion | Alliance |
| 06.03.2023 07:00 | FAB | Trading Statement | RNS |
| 09.02.2023 11:43 | FAB | Fusion Antibodies launches first commercial service from OptiMAL | Alliance |
| 09.02.2023 07:00 | FAB | R&D update: Mammalian Display service | RNS |
| 09.01.2023 16:40 | FAB | Second Price Monitoring Extn | RNS |
| 09.01.2023 16:35 | FAB | Price Monitoring Extension | RNS |
| 09.01.2023 14:05 | FAB | Second Price Monitoring Extn | RNS |
| 09.01.2023 14:00 | FAB | Price Monitoring Extension | RNS |
| 09.01.2023 11:05 | FAB | Second Price Monitoring Extn | RNS |
| 09.01.2023 11:00 | FAB | Price Monitoring Extension | RNS |
| 05.12.2022 11:40 | FAB | Fusion Antibodies half-year loss doubles amid investment delays | Alliance |
| 05.12.2022 07:00 | FAB | Half-year Report | RNS |
| 28.11.2022 15:47 | THS, INHC, FAB | UK earnings, trading statements calendar - next 7 days | Alliance |
| 24.11.2022 07:00 | FAB | Notice of Results | RNS |
